SCHEMBL13636788

SCHEMBL13636788

C[Si](C)(C)c1cc(/C=C/c2ccc(N(c3ccc(/C=C/c4ccc(F)c([Si](C)(C)C)c4)cc3)c3ccc(/C=C/c4ccc(F)c([Si](C)(C)C)c4)cc3)cc2)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 6/20 0.43
APP P05067 6/20 0.41
MAT2A P31153 1/20 0.39
KCNH2 Q12809 1/20 0.39
MAPT P10636 4/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
ALOX15 P16050 1/20 0.36
CASP1 P29466 1/20 0.36
RAB9A P51151 1/20 0.36
HBB P68871 1/20 0.36
NQO2 P16083 1/20 0.35
RELA Q04206 1/20 0.34
PTGS1 P23219 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
ALPG P10696 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13636783 0.87 NFE2L2 (0.43) NFE2L2APPMAT2AKCNH2MAPT
SCHEMBL13636747 0.78 NFE2L2 (0.62) NFE2L2APPMAT2AKCNH2MAPT
SCHEMBL13978808 0.74 NFE2L2 (0.52) NFE2L2APPMAT2AKCNH2MAPT
SCHEMBL13636762 0.73 PTGS1 (0.49) NFE2L2APPMAT2AKCNH2MAPT
SCHEMBL13636785 0.73 NFE2L2 (0.47) NFE2L2APPMAT2AKCNH2MAPT
SCHEMBL9604058 0.72 MAPT (0.44) APPMAT2AKCNH2MAPTMEN1
SCHEMBL13636784 0.72 PTGS1 (0.42) APPMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL13636781 0.71 APP (0.46) NFE2L2APPMAT2AKCNH2MAPT
SCHEMBL13636752 0.71 TUBB1 (0.50) NFE2L2APPMAT2AKCNH2MAPT
SCHEMBL13636757 0.70 PTGS1 (0.45) NFE2L2APPMAT2AKCNH2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957605-B1 ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-01-11 EP disclosed
US-8785001-B2 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-07-22 US disclosed
US-8785001-B2 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-07-22 US disclosed
US-8304095-B2 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-11-06 US disclosed
US-20080297037-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-12-04 US disclosed
US-20080272693-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080272693-A1 Organic Electroluminescent Devices EML4, MT-ND4L, EPCAM NFE2L2 423/4885APP 2549/4885MAT2A 4277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.